Glucocorticoid Treatment in Transaortic Valve Replacement to Reduce the Incidence of Conduction Disturbances (GLUCO-TAVR).

NCT06076824 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Heart Block
Aortic Stenosis
Bundle-Branch Block

Interventions

DRUG: Methylprednisolone
OTHER: Placebo

Sponsor

Hospital General Universitario de Alicante